Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intravenous Dexamethasone for ESP Block Analgesia in Children Undergoing Idiopathic Scoliosis Surgery
Sponsor: Poznan University of Medical Sciences
Summary
This randomized, double-blind, placebo-controlled study will evaluate the effect of intravenous dexamethasone on postoperative analgesia in children and adolescents undergoing surgery for idiopathic scoliosis with bilateral erector spinae plane (ESP) blocks. Participants will be randomly assigned in a 1:1:1 ratio to receive intravenous placebo, dexamethasone 0.1 mg/kg, or dexamethasone 0.2 mg/kg. All participants will receive standardized general anesthesia, bilateral ultrasound-guided ESP blocks, and multimodal postoperative analgesia. The study will evaluate postoperative opioid requirements and the duration and quality of postoperative analgesia. Secondary outcomes will include postoperative pain intensity, time to first rescue opioid administration, the proportion of participants requiring rescue opioid analgesia, postoperative nausea and vomiting, blood glucose concentrations, and adverse events. The study aims to determine whether intravenous dexamethasone improves postoperative analgesia following ESP block and whether the analgesic effect differs between the two studied dexamethasone doses.
Official title: Effect of Two Doses of Intravenous Dexamethasone on Postoperative Analgesia After Erector Spinae Plane Block in Children Undergoing Surgery for Idiopathic Scoliosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Key Details
Gender
All
Age Range
10 Years - 18 Years
Study Type
INTERVENTIONAL
Enrollment
90
Start Date
2026-11-01
Completion Date
2028-01-01
Last Updated
2026-10-22
Healthy Volunteers
No
Conditions
Interventions
Dexamethasone (0.1 mg/kg)
Dexamethasone will be administered intravenously as a single perioperative dose according to randomized treatment allocation: 0.1 mg/kg (maximum dose 4 mg).
Dexamethasone (0.2 mg/kg)
Dexamethasone will be administered intravenously as a single perioperative dose according to randomized treatment allocation: 0.2 mg/kg (maximum dose 8 mg).
Placebo
0.9% sodium chloride will be administered intravenously as placebo according to randomized treatment allocation.
Locations (1)
Poznan University of Medical Sciences
Poznan, Poland